Indications and uses
CORVITA™ Multivitamins/Minerals with Iron tablets are indicated for the distinctive nutritional requirements of persons being treated for vitamin deficiencies by a physician.
Corvita
- Manufacturer
- Trigen Laboratories, LLC
- Effective date
- 2021-12-20
- Label type
- DIETARY SUPPLEMENT
- Version
- 8
- Source
- full-release
- Hydrated at
- 2026-06-01 02:50:19
Label at a glance#
ProductCorvita
Active ingredientBETA CAROTENE, .ALPHA.-TOCOPHEROL SUCCINATE, D-, cholecalciferol, ascorbic acid, thiamine mononitrate, riboflavin, niacinamide, folic acid, pyridoxine Hydrochloride, Biotin, Pantothenic Acid, cyanocobalamin, Magnesium oxide, Zinc oxide, SODIUM SELENATE, Chromium picolinate, Copper gluconate, IRON, Lutein, Lycopene, THIOCTIC ACID
Label structure13 sections
Dosage and administration
Usual adult dosage is one bisected tablet daily, or as prescribed by a physician.
Contacts and useful links#
Websitewww.fda.gov
www.fda.gov/medwatch
www.fda.gov/medwatchLabel contents#
Full prescribing information#
SUPPLEMENT FACTS
Other Ingredients: Silicified Microcrystalline Cellulose, Microcrystalline Cellulose, Green Color Coating (Hydroxypropylmethyl Cellulose, Titanium Dioxide, Polyvinyl Alcohol, Triacetin, Talc, FD&C Yellow #5 Lake, FD&C Blue #2 Lake, FD&C Yellow #6 Lake), Croscarmellose Sodium, Fumed Silica, Tri- Potassium Citrate, Magnesium Stearate, Stearic Acid, and Citric Acid.
Sugar, Lactose, and Gluten Free
CORVITA™ is a prescribed Multivitamin/Mineral Supplement with Iron that is specially formulated and indicated for the distinct nutritional requirements of individuals with vitamin deficiencies.
INDICATIONS AND USAGE
CORVITA™ Multivitamins/Minerals with Iron tablets are indicated for the distinctive nutritional requirements of persons being treated for vitamin deficiencies by a physician.
CONTRAINDICATIONS
CORVITA™ Multivitamin/Mineral Supplement with Iron tablets should not be used by patients with known history of hypersensitivity to any of the listed ingredients or as directed by your physician.
WARNING
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
PRECAUTIONS
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily, may obscure pernicious anemia assessment, such that hematologic remission can occur while neurological manifestations remain progressive.
This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
Biotin levels higher than the recommended daily allowance may cause interference with some laboratory tests, including cardiovascular diagnostic test (e.g. troponin) and hormone tests, and may lead to incorrect test results. Tell your healthcare provider about all prescription and over-the-counter medicines, vitamins, and dietary supplements that you take, including biotin.
DRUG INTERACTIONS
CORVITA™ Multivitamin & Mineral Supplement with Iron tablets are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
ADVERSE REACTIONS
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained in CORVITA™. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels has been associated with gastrointestinal intolerance in some patients.
DESCRIPTION
CORVITA™ is a green coated, oval shaped tablet debossed with “VP 011”on one side, bisect on the other side.
DIRECTIONS FOR USE
Usual adult dosage is one bisected tablet daily, or as prescribed by a physician.
HOW SUPPLIED
Corvita™ tablets are supplied in bottles of 100 tablets.
Product Code: 13811-028-10
STORAGE
Store at 20°-25°C (68°-77°F), excursion permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined by the USP with a child-resistant closure.
HEALTH CLAIM SECTION
KEEP OUT OF REACH OF CHILDREN.
For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, call Trigen Laboratories, LLC at 1-770-509-4500 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
PLR-CORVITA-00001-02 Rev. 12/2021
Manufactured for: 
Trigen Laboratories, LLC
Alpharetta, GA 30005
1-770-509-4500
PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Label
13811-028-10
CORVITA™ TABLETS
MULTIVITAMIN / MINERAL SUPPLEMENT WITH IRON
Sugar, Lactose and Gluten Free
100 TABLETS
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13811-028-10 | Corvita | 100 in 1 BOTTLE | TABLET, COATED | 100 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 13811-028 | CORVITA (.BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, PANTOTHENIC ACID, IRON, MAGNESIUM OXIDE, ZINC OXIDE, SELENOMETHIONINE, COPPER GLUCONATE, CHROMIUM PICOLINATE, THIOCTIC ACID, LUTEIN, AND LYCOPENE) TABLET, COATED [TRIGEN LABORATORIES, LLC] | 8 | 1 package rows | 20220108_c920c091-1eef-49e1-a697-eb5bf6aae145.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13811-028-10 | EA - Each | 13811-028 | 36a8eed8-8722-4101-9caf-9e66eb71eb54 | 1 | 2013-06-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .Alpha.-Lipoic Acid | ACTIVE INGREDIENT | 73Y7P0K73Y | 1 | |
| .ALPHA.-TOCOPHEROL SUCCINATE, D- | ACTIVE INGREDIENT | LU4B53JYVE | 1 | |
| .beta.-carotene | ACTIVE INGREDIENT | 01YAE03M7J | 1 | |
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| Biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 1 | |
| Chromium picolinate | ACTIVE INGREDIENT | S71T8B8Z6P | 1 | |
| Copper gluconate | ACTIVE INGREDIENT | RV823G6G67 | 1 | |
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| folic acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| Lutein | ACTIVE INGREDIENT | X72A60C9MT | 1 | |
| Lycopene | ACTIVE INGREDIENT | SB0N2N0WV6 | 1 | |
| Magnesium oxide | ACTIVE INGREDIENT | 3A3U0GI71G | 1 | |
| niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| Pantothenic Acid | ACTIVE INGREDIENT | 19F5HK2737 | 1 | |
| pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| Selenomethionine | ACTIVE INGREDIENT | 964MRK2PEL | 1 | |
| thiamine mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 1 | |
| Zinc oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| .Alpha.-Lipoic Acid | ACTIVE MOIETY | 73Y7P0K73Y | 1 | |
| .ALPHA.-TOCOPHEROL, D- | ACTIVE MOIETY | N9PR3490H9 | 1 | |
| .beta.-carotene | ACTIVE MOIETY | 01YAE03M7J | 1 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| Biotin | ACTIVE MOIETY | 6SO6U10H04 | 1 | |
| cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 1 | |
| CHROMIC CATION | ACTIVE MOIETY | X1N4508KF1 | 1 | |
| CUPRIC CATION | ACTIVE MOIETY | 8CBV67279L | 1 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 1 | |
| folic acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| Lutein | ACTIVE MOIETY | X72A60C9MT | 1 | |
| Lycopene | ACTIVE MOIETY | SB0N2N0WV6 | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| Pantothenic Acid | ACTIVE MOIETY | 19F5HK2737 | 1 | |
| pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| riboflavin | ACTIVE MOIETY | TLM2976OFR | 1 | |
| selenomethionine | ACTIVE MOIETY | 964MRK2PEL | 1 | |
| THIAMINE ION | ACTIVE MOIETY | 4ABT0J945J | 1 | |
| Zinc oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| Aluminum Oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| citric acid monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| croscarmellose sodium | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| ethylcelluloses | INACTIVE INGREDIENT | 7Z8S9VYZ4B | 1 | |
| FD&C Blue No. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 1 | |
| FD&C Yellow No. 5 | INACTIVE INGREDIENT | I753WB2F1M | 1 | |
| ferrosoferric oxide | INACTIVE INGREDIENT | XM0M87F357 | 1 | |
| hydroxypropyl cellulose (type h) | INACTIVE INGREDIENT | RFW2ET671P | 1 | |
| hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| polyethylene glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| potassium citrate anhydrous | INACTIVE INGREDIENT | 86R1NVR0HW | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 |
Products#
Every source-derived product name is available through these pages.
- Corvita
- .beta.-carotene, ascorbic acid, cholecalciferol, .ALPHA.-TOCOPHEROL SUCCINATE, D-, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hydrochloride, folic acid, cyanocobalamin, Biotin, Pantothenic Acid, Iron, Magnesium oxide, Zinc oxide, Selenomethionine, Copper Gluconate, Chromium picolinate, Thioctic Acid, Lutein, and Lycopene
- BETA CAROTENE
- .ALPHA.-TOCOPHEROL SUCCINATE, D-
- .ALPHA.-TOCOPHEROL, D-
- cholecalciferol
- ascorbic acid
- thiamine mononitrate
- THIAMINE ION
- Thiamine
- riboflavin
- niacinamide
- folic acid
- pyridoxine Hydrochloride
- pyridoxine
- Biotin
- Pantothenic Acid
- cyanocobalamin
- Magnesium oxide
- MAGNESIUM CATION
- Zinc oxide
- SODIUM SELENATE
- SELENATE ION
- SELENIUM
- Chromium picolinate
- CHROMIC CATION
- Copper gluconate
- CUPRIC CATION
- IRON
- Lutein
- Lycopene
- THIOCTIC ACID
- Cellulose, Microcrystalline
- croscarmellose sodium
- titanium dioxide
- potassium citrate anhydrous
- stearic acid
- magnesium stearate
- citric acid monohydrate
- talc
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 13811-028 | 13811-028-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| talc | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| ethylcelluloses | ETHYLCELLULOSE | 7Z8S9VYZ4B | TABLET, COATED / ORAL | 20 mg | ||
| hydroxypropyl cellulose (type h) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | LOTION / TOPICAL | 6 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| FD&C Blue No. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LIQUID / ORAL | NA | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, EXTENDED RELEASE / ORAL | 53 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 0.1 %w/w | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | OINTMENT / TOPICAL | 5 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| FD&C Blue No. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| FD&C Blue No. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, COATED / ORAL | 0.52 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRAVITREAL | 0.02 %w/v | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| FD&C Blue No. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SOLUTION / RECTAL | 0.01 %w/v | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRAMUSCULAR | 4 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRASYNOVIAL | 4 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| hydroxypropyl cellulose (type h) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 39.2 mg | ||
| hydroxypropyl cellulose (type h) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, EXTENDED RELEASE / ORAL | 864 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 34 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| ferrosoferric oxide | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, COATED / ORAL | NA | ||
| hydroxypropyl cellulose (type h) | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE, EXTENDED RELEASE / ORAL | 204 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, SUSPENSION / INTRA-ARTICULAR | 4 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRALESIONAL | 4 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| croscarmellose sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TROCHE / ORAL | 50 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | POWDER / ORAL | 66 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| stearic acid | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / AURICULAR (OTIC) | 0.04 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | GEL / TOPICAL | 12 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| citric acid monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION / INTRAVENOUS | 4680 mg | ||
| hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.